Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases. (Q51548093)

6 April 2018

title

Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases. (English)

1 reference

6 April 2018

author

Ferdinand von Eggeling

7

1 reference

6 April 2018

author name string

Nicole Posorski

1

1 reference

6 April 2018

Daniel Kaemmerer

2

1 reference

6 April 2018

Guenther Ernst

3

1 reference

6 April 2018

Patricia Grabowski

4

1 reference

6 April 2018

Dieter Hoersch

5

1 reference

6 April 2018

Merten Hommann

6

1 reference

6 April 2018

publication date

17 June 2011

1 reference

6 April 2018

Clinical & Experimental Metastasis

published in

1 reference

6 April 2018

volume

28

1 reference

6 April 2018

issue

7

1 reference

6 April 2018

page(s)

637-647

1 reference

6 April 2018

https://scigraph.springernature.com/pub.10.1007/s10585-011-9397-5

exact match

0 references

cites work

Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

The Ki-67 protein: from the known and the unknown

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Molecular mechanisms of enteroendocrine differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

The molecular genetics of gastroenteropancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Colon-derived liver metastasis, colorectal carcinoma, and hepatocellular carcinoma can be discriminated by the Ca(2+)-binding proteins S100A6 and S100A11

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Gastroenteropancreatic neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Towards a novel classification of human malignancies based on gene expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

A technical triade for proteomic identification and characterization of cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Technical aspects of immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Multi-platform, multi-site, microarray-based human tumor classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Chromosome aberrations in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Multiclass cancer diagnosis using tumor gene expression signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Molecular classification of multiple tumor types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

A quantitative reverse transcriptase-polymerase chain reaction assay to identify metastatic carcinoma tissue of origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Interlaboratory performance of a microarray-based gene expression test to determine tissue of origin in poorly differentiated and undifferentiated cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Implementation of a novel microarray-based diagnostic test for cancer of unknown primary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Molecular genetic events in gastrointestinal and pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Microdissecting the proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

The novel endocytic and phagocytic C-Type lectin receptor DCL-1/CD302 on macrophages is colocalized with F-actin, suggesting a role in cell adhesion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Hodgkin's lymphoma cell lines express a fusion protein encoded by intergenically spliced mRNA for the multilectin receptor DEC-205 (CD205) and a novel C-type lectin receptor DCL-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

The crystal structure of human WD40 repeat-containing peptidylprolyl isomerase (PPWD1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Endocrine pancreatic tumors: factors correlated with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9397-5

Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin

21 January 2018

1 reference

12 December 2020

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.

1 reference

12 December 2020

Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.

1 reference

12 December 2020

Molecular classification of human carcinomas by use of gene expression signatures.

1 reference

12 December 2020

IL-6-174 C/G polymorphism in the gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

1 reference

12 December 2020

Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors

1 reference

12 December 2020

Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread

1 reference

12 December 2020

RET proto-oncogene point mutations in sporadic neuroendocrine tumors

1 reference

12 December 2020

[The initial CUP situation and CUP syndrome: pathological diagnostics]

1 reference

12 December 2020

Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry.

1 reference

12 December 2020

Genomic imbalances in the progression of endocrine pancreatic tumors

1 reference

12 December 2020

Molecular genetics of neuroendocrine tumors

1 reference

12 December 2020

Molecular classification of human cancers using a 92-gene real-time quantitative polymerase chain reaction assay.

1 reference

12 December 2020

Identifying tumor origin using a gene expression-based classification map.

1 reference

12 December 2020

Microdissected tissue: an underestimated source for biomarker discovery?

1 reference

12 December 2020

Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma

1 reference

12 December 2020

[Gastrointestinal neuroendocrine tumors]

1 reference

12 December 2020

Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin

1 reference

12 December 2020

Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients

1 reference

12 December 2020

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary

1 reference

12 December 2020

Frequent deletion of chromosome 3 in malignant sporadic pancreatic endocrine tumors

1 reference

12 December 2020

Deletion at 3p25.3-p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression

1 reference

12 December 2020

Chromosome 18 deletions are common events in classical midgut carcinoid tumors

1 reference

12 December 2020

High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss

1 reference

12 December 2020

10.1007/S10585-011-9397-5

Identifiers

DOI

1 reference

6 April 2018

PubMed ID

21681495

1 reference

6 April 2018